VIRAL NANOTECHNOLOGY VIRAL NANOTECHNOLOGY Edited by Yury Khudyakov Centers for Disease Control and Prevention Atlanta, Georgia, USA Paul Pumpens Latvian Biomedical Research and Study Centre Riga, Latvia Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2016 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Version Date: 20150428 International Standard Book Number-13: 978-1-4665-8353-5 (eBook - PDF) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers. For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged. Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe. Visit the Taylor & Francis Web site at http://www.taylorandfrancis.com and the CRC Press Web site at http://www.crcpress.com Contents Preface......................................................................................................................................................................................... ix Editors ......................................................................................................................................................................................... xi Contributors ...............................................................................................................................................................................xiii Introduction .............................................................................................................................................................................. xvii SECTION I Major Concepts Chapter 1 Introduction to Capsid Architecture ........................................................................................................................ 3 Kaspars Tars Chapter 2 Self-Assembling Virus-Like and Virus-Unlike Particles ..................................................................................... 13 Adam Zlotnick, Samson Francis, Lye Siang Lee, and Joseph Che-Yen Wang Chapter 3 Electron Cryomicroscopy and Image Reconstruction of Viral Nanoparticles ..................................................... 27 Bettina Böttcher Chapter 4 X-Ray Analysis of Viral Nanoparticles ................................................................................................................. 61 Kaspars Tars Chapter 5 Computational Methods for Engineering Protein 3D Nano-Objects .................................................................... 75 James Lara and Xiaojun Xu Chapter 6 Viral Nanoparticles: Principles of Construction and Characterization ................................................................ 93 Andris Zeltins Chapter 7 Immunology of Virus-Like Particles .................................................................................................................. 121 Martin F. Bachmann and Franziska Zabel Chapter 8 Nanomedicine: General Considerations and Examples ...................................................................................... 129 Kenza Snoussi and Michael Kann SECTION II Applications Chapter 9 Virus-Like Particles: A Versatile Tool for Basic and Applied Research on Emerging and Reemerging Viruses .................................................................................................................................. 137 Sandra Diederich, Alma Gedvilaite, Aurelija Zvirbliene, Andris Kazaks, Kestutis Sasnauskas, Nicholas Johnson, and Rainer G. Ulrich Chapter 10 Virus-Like Particles Derived from Hepatitis Viruses ..........................................................................................161 Wolfram H. Gerlich v vi Contents Chapter 11 History and Potential of Hepatitis B Virus Core as a VLP Vaccine Platform .................................................... 177 Hadrien Peyret, Sam L. Stephen, Nicola J. Stonehouse, and David J. Rowlands Chapter 12 SplitCore: Advanced Nanoparticulate Molecular Presentation Platform Based on the Hepatitis B Virus Capsid ............................................................................................................... 187 Philipp Kolb, Thi Thai An Nguyen, Andreas Walker, and Michael Nassal Chapter 13 Use of VLPs in the Design of Malaria Vaccines ................................................................................................ 209 David Whitacre, Diego Espinosa, Darrell Peterson, Fidel Zavala, and David R. Milich Chapter 14 Use of HBcAg as an Adjuvant in DNA-Based Vaccines: An Unexpected Journey ............................................ 233 Matti Sällberg Chapter 15 Bacteriophage Virus-Like Particles as a Platform for Vaccine Discovery ......................................................... 239 Bryce Chackerian and David S. Peabody Chapter 16 Production of Virus-Like Particles in Plants ...................................................................................................... 251 Pooja Saxena and George P. Lomonossoff Chapter 17 Bionanomaterials from Plant Viruses ................................................................................................................. 263 Alaa A.A. Aljabali and David J. Evans Chapter 18 Assembly of a Bluetongue Virus-Like Particle: Multiprotein Complex and Its Use as Vaccine ........................ 279 Avnish Patel and Polly Roy Chapter 19 Virus-Like Particles Based on Polyomaviruses and Human Papillomaviruses as Vectors for Vaccines, Preventive and Therapeutic Immunotherapy, and Gene Delivery ................................................ 295 Tina Dalianis Chapter 20 Applications of Viral Nanoparticles Based on Polyomavirus and Papillomavirus Structures ........................... 303 Jiřina Suchanová, Hana Španielová, and Jitka Forstová Chapter 21 Nanoparticles of Norovirus ................................................................................................................................. 363 Ming Tan and Xi Jiang Chapter 22 Virus-Like Particle Enzyme Encapsulation: Conned Catalysis and Metabolic Materials ............................... 371 Benjamin Schwarz, Dustin Patterson, and Trevor Douglas Chapter 23 Principles of Design of Virus Nanoparticles for Imaging Applications ............................................................. 383 Irina Tsvetkova and Bogdan Dragnea Chapter 24 Enveloped Viruses with Single-Stranded Negative RNA Genome as Objects and Subjects of VLP Nanotechnology ................................................................................................................ 391 Peter Pushko and Paul Pumpens Contents vii Chapter 25 Traditional and Novel Trends in Inuenza Vaccines ...........................................................................................419 Peter Pushko and Terrence M. Tumpey Chapter 26 Retrovirus-Derived Virus-Like Particles ............................................................................................................ 449 Bertrand Bellier, Charlotte Dalba, and David Klatzmann Chapter 27 Cancer Therapy Applying Viral Nanoparticles .................................................................................................. 455 Kenneth Lundstrom Chapter 28 Alphaviral Vectors for Cancer Treatment ........................................................................................................... 467 Anna Zajakina, Jelena Vasilevska, Tatjana Kozlovska, and Kenneth Lundstrom Chapter 29 Synthetic Virus-Like Particles in Vaccine Design .............................................................................................. 487 Arin Ghasparian and John A. Robinson Preface Nature works as small as it wishes. fabrication of materials with novel properties, which cannot be otherwise obtained, offers opportunities for a multitude Contemplation de la Nature (1764) of unique applications affecting all human activities. The Charles Bonnet (1720–1793) unique properties of viral proteins, such as their capability to be robustly assembled into well-dened multivalent architec-